Latest Allarity Therapeutics News & Updates

See the latest news and media coverage for Allarity. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Allarity Therapeutics (Allarity)

Clinical-stage precision medicine company for oncology

allarity.com
Headquarters
Tarpon Springs, United States
Founded year
2012
Company type
Public company
Number of employees
10–50
Industry
Pharmaceuticals

Last updated

Latest news about Allarity Therapeutics (Allarity)

In short: Allarity reached Phase 3-ready manufacturing for stenoparib, secured U.S. patents for its DRP diagnostic, and reported $26.9 million in cash.

Company announcements

Allarity

Allarity receives Japanese patent

The Japan Patent Office granted Allarity a patent for its stenoparib DRP companion diagnostic, securing protection through 2039.

Allarity

Allarity announces grant of key US patent for stenoparib DRP diagnostic

The patent extends protection into April 2042 and covers methods for selecting patients likely to benefit from stenoparib treatment.

Unlock all announcements with a

Media coverage

MarketWatch

Allarity Acquisition Corp. Files for IPO

Allarity Acquisition Corp. has filed for an initial public offering. The special-purpose acquisition company said it will sell 10 million units at $10 apiece, each...

Barron's

Allarity Therapeutics Inc.

Allarity Therapeutics Inc. company and executive profile by Barron's. View the latest ALLR company infomation and executive bios.

The Globe and Mail

Allarity Therapeutics Secures $20 Million Structured Note Financing

An update from Allarity Therapeutics ( (ALLR)) is now available. On March 2, 2026, Allarity Therapeutics entered into a note purchase agreement with Streeterville Capital...

Unlock all articles with a

Never miss news about Allarity

Track Allarity and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Allarity competitors & trending companies

Browse news for competitors to Allarity and other trending companies.